Characterization of bone homeostasis in individuals affected by cardio‐facio‐cutaneous syndrome
- 2 December 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 188 (2) , 414-421
Abstract
Cardio-facio-cutaneous syndrome (CFCS) is a rare disorder characterized by distinctive craniofacial appearance, cardiac, neurologic, cutaneous, and musculoskeletal abnormalities. It is due to heterozygous mutations in BRAF, MAP2K1, MAP2K2, and KRAS genes, belonging to the RAS/MAPK pathway. The role of RAS signaling in bone homeostasis is highly recognized, but data on bone mineral density (BMD) in CFCS are lacking. In the present study we evaluated bone parameters, serum and urinary bone metabolites in 14 individuals with a molecularly confirmed diagnosis of CFCS. Bone assessment was performed through dual X-ray absorptiometry (DXA); height-adjusted results were compared to age- and sex-matched controls. Blood and urinary bone metabolites were also analyzed and compared to the reference range. Despite vitamin D supplementation and almost normal bone metabolism biomarkers, CFCS patients showed significantly decreased absolute values of DXA-assessed subtotal and lumbar BMD (p ≤ 0.05), compared to controls. BMD z-scores and t-scores (respectively collected for children and adults) were below the reference range in CFCS, while normal in healthy controls. These findings confirmed a reduction in BMD in CFCS and highlighted the importance of monitoring bone health in these affected individuals.Keywords
This publication has 43 references indexed in Scilit:
- Decreased bone mineralization in children with Noonan syndrome: Another consequence of dysregulated RAS MAPKinase pathway?Molecular Genetics and Metabolism, 2012
- Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type IHuman Molecular Genetics, 2011
- Neurofibromin (Nf1) is required for skeletal muscle developmentHuman Molecular Genetics, 2011
- Noonan syndrome and clinically related disordersBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- Bone resorption in syndromes of the Ras/MAPK pathwayClinical Genetics, 2010
- Disorders of dysregulated signal traffic through the RAS‐MAPK pathway: phenotypic spectrum and molecular mechanismsAnnals of the New York Academy of Sciences, 2010
- Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of Calcium, Vitamin B12, Iron, and MagnesiumCurrent Gastroenterology Reports, 2010
- Bone Mineral Density in Children and Adolescents with Neurofibromatosis Type 1The Journal of Pediatrics, 2007
- ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiaeCell Metabolism, 2006
- The cardiofaciocutaneous syndromeJournal of Medical Genetics, 2006